ArticleJournal of experimental & clinical cancer research : CR2026
Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.
Katie Stoker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.